Literature DB >> 16142741

Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages.

Ryusaku Nagayoshi1, Taku Nagai, Kakushi Matsushita, Katsuaki Sato, Nobuhiko Sunahara, Takemasa Matsuda, Tadashi Nakamura, Setsuro Komiya, Masanori Onda, Takami Matsuyama.   

Abstract

OBJECTIVE: To define the distribution of folate receptor beta (FRbeta)-expressing cells in various tissues, including rheumatoid arthritis (RA) synovial tissues, and to verify the effects of an immunotoxin composed of an anti-FRbeta monoclonal antibody (mAb) and truncated Pseudomonas exotoxin A (PEA) on apoptosis and tumor necrosis factor alpha (TNFalpha) production by adherent synovial mononuclear cells from RA patients.
METHODS: Anti-FRbeta mAb were produced by immunizing mice with FRbeta-transfected murine pre-B cells. The distribution of the FRbeta antigen was examined by immunohistochemical analysis using anti-FRbeta mAb and macrophage-specific anti-CD163 mAb. Anti-FRbeta mAb was chemically crosslinked with truncated PEA. FRbeta-expressing macrophages were produced by the transfection of adenovirus vector containing the FRbeta gene. Apoptotic cells were detected by staining with propidium iodide. TNFalpha was measured by enzyme-linked immunosorbent assay.
RESULTS: FRbeta-expressing cells were not present in peripheral blood leukocytes and their activated cells. In all of the tissues examined, most FRbeta-expressing cells were CD163+. The immunotoxin significantly induced the apoptosis of FRbeta-transfected macrophages and adherent RA synovial mononuclear cells and inhibited TNFalpha production by adherent RA synovial mononuclear cells.
CONCLUSION: We demonstrated the limited distribution of FRbeta-expressing cells in various tissues. The immunotoxin targeting FRbeta-expressing cells will provide a therapeutic tool for rheumatoid synovitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142741     DOI: 10.1002/art.21228

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  23 in total

1.  Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer.

Authors:  M Tanaka; T Nagai; Y Tsuneyoshi; N Sunahara; T Matsuda; T Nakamura; S Tsuyama; K Hasui; O FitzGerald; T Matsuyama
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

2.  Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.

Authors:  Thommey P Thomas; Sascha N Goonewardena; Istvan J Majoros; Alina Kotlyar; Zhengyi Cao; Pascale R Leroueil; James R Baker
Journal:  Arthritis Rheum       Date:  2011-09

3.  Serum-soluble folate receptor β as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.

Authors:  Hideo Otsubo; Yasuhiro Tsuneyoshi; Tadashi Nakamura; Takemasa Matsuda; Setsuro Komiya; Takami Matsuyama
Journal:  Clin Rheumatol       Date:  2018-07-18       Impact factor: 2.980

4.  Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.

Authors:  Saijie Zhu; Mengmeng Niu; Hannah O'Mary; Zhengrong Cui
Journal:  Mol Pharm       Date:  2013-08-06       Impact factor: 4.939

5.  Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.

Authors:  Otilia May Yue Koo; Israel Rubinstein; Hayat Onyüksel
Journal:  Pharm Res       Date:  2010-12-04       Impact factor: 4.200

6.  Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma.

Authors:  Koji Minami; Kiyokazu Hiwatashi; Shinichi Ueno; Masahiko Sakoda; Satoshi Iino; Hiroshi Okumura; Motoyuki Hashiguchi; Yota Kawasaki; Hiroshi Kurahara; Yuko Mataki; Kosei Maemura; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Exp Ther Med       Date:  2018-03-14       Impact factor: 2.447

Review 7.  Innate immunity and rheumatoid arthritis.

Authors:  Angelica Gierut; Harris Perlman; Richard M Pope
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

8.  Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis.

Authors:  Bindu Varghese; Chrystal Paulos; Philip S Low
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

9.  Efficacy of an immunotoxin to folate receptor beta in the intra-articular treatment of antigen-induced arthritis.

Authors:  Taku Nagai; Akira Kyo; Kazuhisa Hasui; Sonshin Takao; Takami Matsuyama
Journal:  Arthritis Res Ther       Date:  2012-05-02       Impact factor: 5.156

10.  Folate receptor: a macrophage "achilles' heel"?

Authors:  Ingo Hilgendorf; Filip K Swirski
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.